Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
3.220
-0.010 (-0.31%)
At close: Nov 4, 2024, 4:00 PM
3.230
+0.010 (0.31%)
After-hours: Nov 4, 2024, 5:30 PM EST

Xeris Biopharma Holdings Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2016
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2016
Revenue
181.41163.91110.2549.5920.442.72
Upgrade
Revenue Growth (YoY)
35.31%48.68%122.32%142.67%650.73%12.34%
Upgrade
Cost of Revenue
29.5328.6522.6313.329.331.6
Upgrade
Gross Profit
151.88135.2787.6136.2711.111.12
Upgrade
Selling, General & Admin
153.23146.1136.26116.0673.7363.06
Upgrade
Research & Development
2522.3420.9725.1618.9260.44
Upgrade
Operating Expenses
189.07179.28168.07141.7792.65123.5
Upgrade
Operating Income
-37.19-44.01-80.45-105.5-81.55-122.38
Upgrade
Interest Expense
-28.86-26.61-14.1-7.18-10.66-7.16
Upgrade
Interest & Investment Income
4.183.492.760.731.472.81
Upgrade
Other Non Operating Income (Expenses)
0.0201.76-0.7-0.010.69
Upgrade
EBT Excluding Unusual Items
-61.85-67.13-90.03-112.66-90.75-126.04
Upgrade
Merger & Restructuring Charges
---1.49-9.66-2-
Upgrade
Gain (Loss) on Sale of Investments
1.261.26-0.18-0.41--
Upgrade
Legal Settlements
----1.5-
Upgrade
Other Unusual Items
1.52.36-4.38---
Upgrade
Pretax Income
-59.08-63.5-96.08-122.73-91.25-126.04
Upgrade
Income Tax Expense
0.48-1.25-1.42--0.11-0.46
Upgrade
Net Income
-59.56-62.26-94.66-122.73-91.14-125.58
Upgrade
Net Income to Common
-59.56-62.26-94.66-122.73-91.14-125.58
Upgrade
Shares Outstanding (Basic)
141138136794326
Upgrade
Shares Outstanding (Diluted)
141138136794326
Upgrade
Shares Change (YoY)
3.38%1.51%71.62%85.32%63.32%116.75%
Upgrade
EPS (Basic)
-0.42-0.45-0.70-1.55-2.14-4.81
Upgrade
EPS (Diluted)
-0.42-0.45-0.70-1.55-2.14-4.81
Upgrade
Free Cash Flow
-38.83-49.29-103.42-96.62-80.94-105.45
Upgrade
Free Cash Flow Per Share
-0.27-0.36-0.76-1.22-1.90-4.04
Upgrade
Gross Margin
83.72%82.52%79.47%73.14%54.35%41.11%
Upgrade
Operating Margin
-20.50%-26.85%-72.97%-212.74%-399.05%-4495.96%
Upgrade
Profit Margin
-32.83%-37.98%-85.86%-247.48%-446.00%-4613.52%
Upgrade
Free Cash Flow Margin
-21.40%-30.07%-93.80%-194.84%-396.06%-3874.10%
Upgrade
EBITDA
-25-31.68-68.21-103.62-80.08-121.3
Upgrade
EBITDA Margin
-13.78%-19.33%-61.87%-208.95%--
Upgrade
D&A For EBITDA
12.1912.3312.241.881.471.08
Upgrade
EBIT
-37.19-44.01-80.45-105.5-81.55-122.38
Upgrade
EBIT Margin
-20.50%-26.85%-72.97%-212.74%--
Upgrade
Revenue as Reported
181.41163.91110.2549.5920.44-
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.